Xiangxue Pharmaceutical Statistics
Total Valuation
SHE:300147 has a market cap or net worth of CNY 6.22 billion. The enterprise value is 7.84 billion.
| Market Cap | 6.22B |
| Enterprise Value | 7.84B |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300147 has 661.28 million shares outstanding. The number of shares has decreased by -0.10% in one year.
| Current Share Class | 661.28M |
| Shares Outstanding | 661.28M |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +4.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.18% |
| Float | 485.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.90 |
| PB Ratio | 141.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 52.68 |
| P/OCF Ratio | 44.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 54.15, with an EV/FCF ratio of 66.37.
| EV / Earnings | -5.63 |
| EV / Sales | 4.91 |
| EV / EBITDA | 54.15 |
| EV / EBIT | n/a |
| EV / FCF | 66.37 |
Financial Position
The company has a current ratio of 0.26, with a Debt / Equity ratio of 33.38.
| Current Ratio | 0.26 |
| Quick Ratio | 0.18 |
| Debt / Equity | 33.38 |
| Debt / EBITDA | 10.13 |
| Debt / FCF | 12.42 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -184.89% and return on invested capital (ROIC) is -3.45%.
| Return on Equity (ROE) | -184.89% |
| Return on Assets (ROA) | -0.67% |
| Return on Invested Capital (ROIC) | -3.45% |
| Return on Capital Employed (ROCE) | -13.34% |
| Weighted Average Cost of Capital (WACC) | 5.96% |
| Revenue Per Employee | 576,167 |
| Profits Per Employee | -502,770 |
| Employee Count | 2,769 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 3.64 |
Taxes
In the past 12 months, SHE:300147 has paid 33.95 million in taxes.
| Income Tax | 33.95M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.62% in the last 52 weeks. The beta is 0.57, so SHE:300147's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +57.62% |
| 50-Day Moving Average | 9.68 |
| 200-Day Moving Average | 9.62 |
| Relative Strength Index (RSI) | 43.92 |
| Average Volume (20 Days) | 18,812,254 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300147 had revenue of CNY 1.60 billion and -1.39 billion in losses. Loss per share was -2.11.
| Revenue | 1.60B |
| Gross Profit | 435.94M |
| Operating Income | -76.60M |
| Pretax Income | -1.34B |
| Net Income | -1.39B |
| EBITDA | 113.65M |
| EBIT | -76.60M |
| Loss Per Share | -2.11 |
Balance Sheet
The company has 254.57 million in cash and 1.47 billion in debt, giving a net cash position of -1.21 billion or -1.83 per share.
| Cash & Cash Equivalents | 254.57M |
| Total Debt | 1.47B |
| Net Cash | -1.21B |
| Net Cash Per Share | -1.83 |
| Equity (Book Value) | 43.95M |
| Book Value Per Share | -0.54 |
| Working Capital | -4.57B |
Cash Flow
In the last 12 months, operating cash flow was 139.63 million and capital expenditures -21.51 million, giving a free cash flow of 118.12 million.
| Operating Cash Flow | 139.63M |
| Capital Expenditures | -21.51M |
| Depreciation & Amortization | 190.25M |
| Net Borrowing | -6.33M |
| Free Cash Flow | 118.12M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 27.32%, with operating and profit margins of -4.80% and -87.26%.
| Gross Margin | 27.32% |
| Operating Margin | -4.80% |
| Pretax Margin | -83.79% |
| Profit Margin | -87.26% |
| EBITDA Margin | 7.12% |
| EBIT Margin | -4.80% |
| FCF Margin | 7.40% |
Dividends & Yields
SHE:300147 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.10% |
| Shareholder Yield | 0.10% |
| Earnings Yield | -22.37% |
| FCF Yield | 1.90% |
Stock Splits
The last stock split was on July 14, 2014. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 14, 2014 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |